Tag: Revenue
Revenues of Indian pharma companies likely to expand by 9-11% in...
Revenues estimated to increase by 9-11% from the US market, and 7-9% each from the European and the domestic markets in FY2025
Nephro Care India plans to raise Rs 35–40 crore from its...
This strategic move will allow NCIL to expand its operations across India
Biocon’s biosimilars revenue crosses milestone of US $1 Billion in FY...
The company garnered an overall revenue of Rs 15,621 Crore in FY24, marking a remarkable 35% growth compared to the previous year
Indian pharma industry likely to reach US$ 130 billion by 2030:...
Need to add 30 lakh new hospital beds; aim to reach 100% health insurance coverage to achieve India’s healthcare vision 2047
Cipla’s revenue crosses Rs 25,000 crore at 24.5% profitability in FY24
Pharmaceutical giant reports strong financial growth in revenue and profitability in FY24, demonstrating resilience and market leadership
Dr Lal PathLabs records revenue of Rs 2,295.8 crore in FY24
The company has posted net profit of Rs 357.7 crores for the Financial Year ended March 31, 2024
Syngene International reports Q4 FY24 consolidated PAT at Rs. 188.6 Cr
The company has reported total income of Rs. 933 crores during the period ended March 31, 2024
Healthy occupancies, ARPOB to drive double-digit revenue growth for hospitals this...
Strong accruals counterweight to high capex spend, supporting credit profiles
Arya.ag attains Rs 4,150 crore in revenue, 36% profit in FY...
Platform facilitates Rs 22,796 crore in transactions, showcasing its scale and impact
Biocon revenue up 59% at Rs 3,929 crore in Q4FY23
The company's revenue in biosimilars is up 114%; research services up 31% and EBITDA at Rs 1,152 crore up 75%